OnCare

OnCare is a rapidly growing Indian healthtech startup dedicated to transforming cancer care by making it more affordable, accessible, and patient-centric. The company’s primary market is India, focusing on regions where specialized oncology services are scarce and prohibitively expensive. They have a team of expert oncologists who offer various treatment options, including surgery, chemotherapy, and immunotherapy. The company focuses on providing compassionate care to patients fighting cancer.

Business Model & Revenue Streams

• Hospital Partnerships: OnCare collaborates with mid-sized hospitals to set up dedicated oncology wings. Revenue is generated through a share of treatment fees, leveraging hospital infrastructure to minimize capital expenditure.

• Direct Patient Services: Patients pay for comprehensive cancer care packages, which include consultations, diagnostics, treatment sessions (chemotherapy, radiation, surgery), and ongoing support. Transparent pricing is a key differentiator.

• On-Call Nursing & Support Services: Additional revenue comes from value-added services such as remote nursing support, side-effect management, and patient education.

• Potential Future Revenue Streams: As the network grows, OnCare may introduce telemedicine, digital health records, and partnerships with pharma and insurance companies.

User/Customer Segmentation

• B2C: Cancer patients and their families seeking affordable, high-quality care.

• B2B: Mid-sized hospitals looking to offer oncology services without heavy upfront investment.

Growth Strategy

• Geographic Expansion: Scaling to 10+ centers in Delhi NCR, Bangalore, and Jaipur over two years, targeting underserved urban and semi-urban areas.

• Partnerships: Expanding the hospital network to increase reach and operational efficiency.

• Brand Awareness: Investing in marketing and patient education to build trust and drive adoption.

• Service Diversification: Exploring telehealth, digital health records, and insurance integration to enhance patient experience and open new revenue streams.

OnCare’s partnership-driven model, focus on affordability, and patient-centric approach set it apart from traditional oncology providers, making it a compelling choice for investors and healthcare stakeholders seeking scalable solutions to India’s cancer care crisis.

Conclusion

OnCare is redefining cancer care in India through innovative hospital partnerships, transparent pricing, and a relentless focus on patient support. With strong early traction, a clear expansion roadmap, and a mission to make quality oncology services accessible to all, OnCare stands out as a high-impact, scalable healthtech venture for investors, researchers, and industry professionals.